drugset / Trial / NCT00538304

A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT00538304

Phase 2 Completed 222 enrolled Allergan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension

Timeline

Start
2007-11
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 1 unknown Other